Transcode Therapeutics (NASDAQ: RNAZ) stock is up 80% premarket this morning. RNAZ stock is also down around 50% from its peak a few days back. So, it’s fair to say that there’s a certain amount of ...

TransCode Therapeutics shares are trading lower by 16% during Monday's session. The company announced a 1-for-33 reverse stock split. Unlock your all-in-one trading dashboard with real-time alerts, ...

Transcode Therapeutics Inc (NASDAQ:RNAZ) shares are trading lower by 62% to $0.30 during Tuesday’s session after the company announced pricing of its public offering. The public offering of 10 million ...

TransCode Therapeutics RNAZ announced that it is floating a secondary issue of around 5.94 million shares of its common stock to the public at an issue price of $1.22 per share, amounting to $7.5 ...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new ...

The price trend for TransCode Therapeutics Inc. (RNAZ) has been bearish lately and the stock has lost 11.3% over the past two weeks. However, the formation of a hammer chart pattern in its last ...

Transcode Therapeutics (NASDAQ: RNAZ) is up 1,969 % in premarket trading today. But the volume of shares traded is all of 727 according to NASDAQ itself. This is not normally how we think of stock ...

TransCode Therapeutics, Inc. (RNAZ) stock price is 9.61 and TransCode Therapeutics, Inc. (RNAZ) 10-day simple moving average is 9.65. TransCode Therapeutics, Inc. (RNAZ) stock price is 9.61 and ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 3 of its ...